Systemic therapies for joint disease in horses

Veterinary Clinics of North America - Equine Practice

Volumn 21, Issue 3, 2005, Pages 547-557

  Fortier, Lisa A ^a  

^a Cornell University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSAMINOGLYCAN; HYALURONIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL; ANIMAL DISEASE; ARTHROPATHY; HORSE; HORSE DISEASE; METHODOLOGY; MULTIMODALITY CANCER THERAPY; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COMBINED MODALITY THERAPY; GLYCOSAMINOGLYCANS; HORSE DISEASES; HORSES; HYALURONIC ACID; JOINT DISEASES;

EQUIDAE; EQUUS CABALLUS;

EID: 27744552494     PISSN: 07490739     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cveq.2005.07.002     Document Type: Review

References (66)

1. K.K. Wu Aspirin and other cyclooxygenase inhibitors: new therapeutic insights Semin Vasc Med 3 2 2003 107 112
2. J. Couzin Drug safety. Withdrawal of Vioxx casts a shadow over COX-2 inhibitors Science 306 5695 2004 384 385
3. J. Couzin Clinical trials. Halt of Celebrex study threatens drug's future, other trials Science 306 5705 2004 2170
4. C. Vanchieri Researchers plan to continue to study COX-2 inhibitors in cancer treatment and prevention J Natl Cancer Inst 97 8 2005 552 553
5. T.D. Warner, F. Giuliano, and I. Vojnovic Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis Proc Natl Acad Sci USA 96 13 1999 7563 7568
6. C. Brideau, S.C. Van, and C.C. Chan In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs, and cats Am J Vet Res 62 11 2001 1755 1760
7. K. Takahashi, S. Hashimoto, and T. Kubo Effect of hyaluronan on chondrocyte apoptosis and nitric oxide production in experimentally induced osteoarthritis J Rheumatol 27 7 2000 1713 1720
8. J. Stove, C. Gerlach, and K. Huch Effects of hyaluronan on proteoglycan content of osteoarthritic chondrocytes in vitro J Orthop Res 20 3 2002 551 555
9. P. Ghosh, and D. Guidolin Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent? Semin Arthritis Rheum 32 1 2002 10 37
10. E.M. Gaughan, A.J. Nixon, and L.P. Krook Effects of sodium hyaluronate on tendon healing and adhesion formation in horses Am J Vet Res 52 1991 764 773
11. L.J. Gift, E.M. Gaughan, and R.M. DeBowes Effects of intra-tendinous sodium hyaluronate on enzyme-induced equine tendinitis [abstract] Vet Surg 21 1992 389
12. D. Lajeunesse, A. Delalandre, and J. Martel-Pelletier Hyaluronic acid reverses the abnormal synthetic activity of human osteoarthritic subchondral bone osteoblasts Bone 33 4 2003 703 710
13. M.A. Popot, Y. Bonnaire, and J. Guechot Hyaluronan in horses: physiological production rate, plasma and synovial fluid concentrations in control conditions and following sodium hyaluronate administration Equine Vet J 36 6 2004 482 487
14. C.E. Kawcak, D.D. Frisbie, and G.W. Trotter Effects of intravenous administration of sodium hyaluronate on carpal joint in exercising horses after arthroscopic surgery and osteochondral fragmentation Am J Vet Res 58 1997 1132 1140
15. A.G. Ogston, and J.E. Stanier The physiological function of hyaluronic acid in synovial fluid; viscous, elastic and lubricant properties J Physiol 119 2-3 1953 244 252
16. E.L. Radin, D.A. Swann, and P.A. Weisser Separation of a hyaluronate-free lubricating fraction from synovial fluid Nature 228 5269 1970 377 378
17. F.C. Linn, and E.L. Radin Lubrication of animal joints III. The effect of certain chemical alterations of the cartilage and lubricant Arthritis Rheum 11 1968 674 682
18. K. Nakamura, S. Yokohama, and M. Yoneda High, but not low, molecular weight hyaluronan prevents T-cell-mediated liver injury by reducing proinflammatory cytokines in mice J Gastroenterol 39 4 2004 346 354
19. M.N. Courel, C. Maingonnat, and P. Bertrand Biodistribution of injected tritiated hyaluronic acid in mice: a comparison between macromolecules and hyaluronic acid-derived oligosaccharides In Vivo 18 2 2004 181 187
20. R.J. Todhunter, and G. Lust Polysulfated glycosaminoglycan in the treatment of osteoarthritis J Am Vet Med Assoc 204 8 1994 1245 1251
21. T. Sadowski, and J. Steinmeyer Effects of polysulfated glycosaminoglycan and triamcinolone acetonide on the production of proteinases and their inhibitors by IL-1alpha treated articular chondrocytes Biochem Pharmacol 64 2 2002 217 227
22. G.W. Trotter, J.V. Yovich, and C.W. McIlwraith Effects of intramuscular polysulfated glycosaminoglycan on chemical and physical defects in equine articular cartilage Can J Vet Res 53 1989 224 230
23. S. Collier, N. Hope, and P. Ghosh Healing of circular defects in the rabbit medial meniscus can occur spontaneously and is not improved by intra-articular hyaluronic acid Vet Comp Orthop Traumatol 9 1996 60 65
24. R.J. Todhunter, N.S. Altman, and F.A. Kallfelz Use of scintimetry to assess effects of exercise and polysulfated glycosaminoglycan on equine carpal joints with osteochondral defects Am J Vet Res 54 1993 997 1006
25. Todhunter RJ, Freeman KP, Yeager AE, et al. Effects of exercise and polysulfated glycosaminoglycan on the development of osteoarthritis in equine carpal joints with osteochondral defects. Vet Surg 1993;22:330-42.
26. S.B. Gustafson, C.W. McIlwraith, and R.L. Jones Comparison of the effect of polysulfated glycosaminoglycan, corticosteroids, and sodium hyaluronate in the potentiation of a subinfective dose of Staphylococcus aureus in the midcarpal joint of horses Am J Vet Res 50 1989 2014 2017
27. A.M. Rashmir-Raven, C.P. Coyne, and B.W. Fenwick Inhibition of equine compliment activity by polysulfated glycosaminoglycans Am J Vet Res 53 1992 87 90
28. S.B. Gustafson, C.W. McIlwraith, and R.L. Jones Further investigations into the potentiation of infection by intra-articular injection of polysulfated glycosaminoglycan and the effect of filtration and intra-articular injection of amikacin Am J Vet Res 50 1989 2018 2022
29. T.S. Barclay, C. Tsourounis, and G.M. McCart Glucosamine Ann Pharmacother 32 5 1998 574 579
30. C.B. Knudson, and W. Knudson Cartilage proteoglycans Semin Cell Dev Biol 12 2 2001 69 78
31. L. Lippiello, J. Woodward, and R. Karpman In vivo chondroprotection and metabolic synergy of glucosamine and chondroitin sulfate Clin Orthop Dec 381 2000 229 240
32. P.S. Chan, J.P. Caron, and G.J. Rosa Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E(2) in articular cartilage explants Osteoarthritis Cartilage 13 5 2005 387 394
33. K.M. Neil, J.P. Caron, and M.W. Orth The role of glucosamine and chondroitin sulfate in treatment for and prevention of osteoarthritis in animals J Am Vet Med Assoc 226 7 2005 1079 1088
34. A.A. Brief, S.G. Maurer, and P.E. Di Cesare Use of glucosamine and chondroitin sulfate in the management of osteoarthritis J Am Acad Orthop Surg 9 2 2001 71 78
35. L. Lippiello Glucosamine and chondroitin sulfate: biological response modifiers of chondrocytes under simulated conditions of joint stress Osteoarthritis Cartilage 11 5 2003 335 342
36. A.J. Matheson, and C.M. Perry Glucosamine: a review of its use in the management of osteoarthritis Drugs Aging 20 14 2003 1041 1060
37. A. Reichelt, K.K. Forster, and M. Fischer Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee. A randomized, placebo-controlled, double-blind study Drug Res 44 1994 75 80
38. B.A. Michel, G. Stucki, and D. Frey Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial Arthritis Rheum 52 3 2005 779 786
39. D. Uebelhart, M. Malaise, and R. Marcolongo Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo Osteoarthritis Cartilage 12 4 2004 269 276
40. C.R. Byron, M.W. Orth, and P.J. Venta Influence of glucosamine on matrix metalloproteinase expression and activity in lipopolysaccharide-stimulated equine chondrocytes Am J Vet Res 64 6 2003 666 671
41. M.W. Orth, T.L. Peters, and J.N. Hawkins Inhibition of articular cartilage degradation by glucosamine-HCl and chondroitin sulphate Equine Vet J Suppl 34 2002 224 229
42. R.R. Hanson, L.R. Smalley, and G.K. Huff Oral treatment with a glucosamine chondroitin sulfate compound for degenerative joint disease in horses: 25 cases Equine Pract 19 9 1997 16 22
43. R.R. Hanson Oral glycosaminoglycans in treatment of degenerative joint disease in horses Equine Pract 18 1996 18 22
44. J. Du, N. White, and N.D. Eddington The bioavailability and pharmacokinetics of glucosamine hydrochloride and chondroitin sulfate after oral and intravenous single dose administration in the horse Biopharm Drug Dispos 25 3 2004 109 116
45. A. Das Jr., and T.A. Hammad Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis Osteoarthritis Cartilage 8 5 2000 343 350
46. C.A. Kirker-Head, and R.P. Kirker-Head Safety of an oral chondroprotective agent in horses Vet Ther 2 4 2001 345 353
47. A.R. Shikhman, D. Amiel, and D. D'Lima Chondroprotective activity of N-acetylglucosamine in rabbits with experimental osteoarthritis Ann Rheum Dis 64 1 2005 89 94
48. L.M. Bui, and T.L. Bierer Influence of green lipped mussels (Perna canaliculus) in alleviating signs of arthritis in dogs Vet Ther 4 4 2003 397 407
49. M.A. Cake, R.A. Read, and B. Guillou Modification of articular cartilage and subchondral bone pathology in an ovine meniscectomy model of osteoarthritis by avocado and soya unsaponifiables (ASU) Osteoarthritis Cartilage 8 6 2000 404 411
50. P. Ghosh The pathobiology of osteoarthritis and the rationale for the use of pentosan polysulfate for its treatment Semin Arthritis Rheum 28 4 1999 211 267
51. P. Ghosh, and M. Smith Osteoarthritis, genetic and molecular mechanisms Biogerontology 3 1-2 2002 85 88
52. C.J. Fuller, P. Ghosh, and A.R. Barr Plasma and synovial fluid concentrations of calcium pentosan polysulphate achieved in the horse following intramuscular injection Equine Vet J 34 1 2002 61 64
53. J.F. Innes, A.R. Barr, and M. Sharif Efficacy of oral calcium pentosan polysulphate for the treatment of osteoarthritis of the canine stifle joint secondary to cranial cruciate ligament deficiency Vet Rec 146 15 2000 433 437
54. S.E. Munteanu, M.Z. Ilic, and C.J. Handley Calcium pentosan polysulfate inhibits the catabolism of aggrecan in articular cartilage explant cultures Arthritis Rheum 43 10 2000 2211 2218
55. S.B. Cohen An update on bisphosphonates Curr Rheumatol Rep 6 1 2004 59 65
56. J.F. Van Offel, A.J. Schuerwegh, and C.H. Bridts Effect of bisphosphonates on viability, proliferation, and dexamethasone-induced apoptosis of articular chondrocytes Ann Rheum Dis 61 10 2002 925 928
57. J.M. Denoix, D. Thibaud, and B. Riccio Tiludronate as a new therapeutic agent in the treatment of navicular disease: a double-blind placebo-controlled clinical trial Equine Vet J 35 4 2003 407 413
58. A. Llavaneras, N.S. Ramamurthy, and P. Heikkila A combination of a chemically modified doxycycline and a bisphosphonate synergistically inhibits endotoxin-induced periodontal breakdown in rats J Periodontol 72 8 2001 1069 1077
59. J.R. O'Dell, K.W. Blakely, and J.A. Mallek Treatment of early seropositive rheumatoid arthritis: a two-year, double-blind comparison of minocycline and hydroxychloroquine Arthritis Rheum 44 10 2001 2235 2241
60. G.N. Smith Jr., L.P. Yu Jr., and K.D. Brandt Oral administration of doxycycline reduces collagenase and gelatinase activities in extracts of human osteoarthritic cartilage J Rheumatol 25 3 1998 532 535
61. G.N. Smith Jr., K.D. Brandt, and K.A. Hasty Procollagenase is reduced to inactive fragments upon activation in the presence of doxycycline Ann NY Acad Sci 732 1994 436 438
62. E.A. Seftor, R.E. Seftor, and D.R. Nieva Application of chemically modified tetracyclines (CMTs) in experimental models of cancer and arthritis Adv Dent Res 12 2 1998 103 110
63. C.H. Evans Gene therapy: what have we accomplished and where do we go from here? J Rheumatol Suppl 72 2005 17 20
64. C.H. Evans Gene therapies for osteoarthritis Curr Rheumatol Rep 6 1 2004 31 40
65. C. Hidaka, L.R. Goodrich, and C.T. Chen Acceleration of cartilage repair by genetically modified chondrocytes over expressing bone morphogenetic protein-7 J Orthop Res 21 4 2003 573 583
66. D.D. Frisbie, S.C. Ghivizzani, and P.D. Robbins Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene Gene Ther 9 1 2002 12 20